Introduction: although drug-related problems (DRPs) are known to be prevalent in elderly patients, the literature on prevention of iatrogenic disease is sparse. The present study addresses this requirement. Objectives: to assess the incidence of DRPs in elderly patients admitted to Tayside hospitals before (phase I) and after (phase H) implementation of preventive strategies. Design: all elderly people admitted to hospital were screened by a pharmacist; individual case reviews were prepared for all those with a potential DRP and reviewed by a three-member panel which made a final decision on the presence of a DRP and its contribution to admission. Setting: all hospital wards admitting elderly patients in the Tayside region of Scotland. Subjects: 1011 elderly patient admissions over a 9-month period (phase I); 857 elderly patient admissions over an 8-month period (phase II). Main outcome measures: incidence of DRPs before and after targeted intervention strategies (information bulletin for general practitioners, patient information leaflet, oral presentation to trainee general practitioners). Results: in phase I, the incidence of DRPs was 144/1011 (14.2%), with 54/1011 (5.3%) of the admissions identified as being definitely or probably drug-related. Non-steroidal anti-innammatory drugs (NSAIDs) were the main drug group involved, being responsible for 15/54 (28%) of admissions primarily due to a DRP. Over 66% of admissions due to adverse effects of NSAIDs were considered to be definitely preventable. In phase n, after targeted intervention strategies, there was no significant reduction in total incidence of DRPs or incidence of DRPs related to NSAIDs. However, there appeared to be an improvement in the first 4 months, and a significant drop in NSAID prescribing in Tayside compared with the rest of Scotland was observed. Conclusion: DRPs remain a significant problem in elderly patients and NSAIDs are the major contributor. The intervention strategies used in the study were not demonstrably effective, but a continuous programme of education may be necessary to limit NSAID use.
Introduction
none of which has targeted an exclusively elderly population [8] [9] [10] [11] [12] [13] [14] . Early studies suggested that many Drug-related problems (DRPs) are prevalent in elderly such problems may be avoidable due to their predictpatients in the community [1, 2] and in hospital [3, 4] , ability [15, 16] , while others have reported that around and are responsible for hospital admission [5] [6] [7] .
half the problems identified were considered to be Preventability has only been assessed in a few studies, preventable [8] [9] [10] [11] [12] [13] [14] 17] .
Differences in data collection methods and definitions and assessment of DRPs mean that it is not always possible to compare directly previous studies in this area. Further, although a few practical suggestions for reducing adverse drug reactions and noncompliance have been proposed, literature on implementation and outcome of these preventive strategies is non-existent.
The objectives of the present study were to:
1. Develop and validate data collection methods to determine the incidence of DRPs in elderly patients admitted to hospital. 2. Assess the contribution of the DRPs identified to hospital admission and the proportion of DRPs perceived as preventable.
Methods
The study was approved by the Tayside committee on medical research ethics. Nine different categories of DRP were identified (Table 1) , based on a previous publication [18] . Each category was further defined in detail, with inclusion and exclusion criteria.
Phase I
The first phase of data collection took place between March and December 1992, in hospitals throughout Tayside in Scotland, on a rotational basis, with each group of wards being studied for a 4-week period. All specialities admitting patients over 65 years of age were included in the study. Initial screening, carried out by the clinical pharmacist for each ward or the research pharmacist (G.C.), recorded demographic details, presenting complaint, diagnosis, disease states, drug therapy (both prescribed and non-prescribed) on admission and an indication of compliance with drug regimen by means of a short structured compliance assessment. For those patients identified as having a potential DRP, further information specific to the type of problem was collected.
A panel was established for the final evaluation of a DRP to determine the causal relationship between the drug and subsequent problem, the role of the DRP as a cause of admission and the severity of the problem. The review panel consisted of a pharmacist (G.C.) and a senior registrar (DJ.G.) and consultant physician (M.E.T.M.) in medicine for the elderly.
All information for each suspected DRP was collated by the research pharmacist and presented in the form of an individual case review. These case reviews were reported objectively, based on information obtained from the case notes, medication chart, nursing notes and patient interview. These were then sent in batches to each member of the reviewing panel. Varying numbers of patients (one to three) considered not to have a DRP were included in each batch of 25 case reviews. Two of the three reviewers were blind to the DRP/non-DRP status of cases. Controls were not formally matched to cases, but all patients were over 65 and from similar wards. The controls therefore had broadly similar histories to other cases and all were taking prescribed or non-prescribed medicines on admission.
Each panellist reviewed the cases independently of the other panel members. For each patient, the reviewer decided whether a DRP existed definitely, possibly or not at all. They then indicated whether they thought the DRP was a definite, probable or possible cause of admission or whether it was unrelated. Definitions for each of these categories were standardized using those described previously [10] . For a DRP to be denned as such required agreement of at least two out of three members of the panel. In all cases of DRPs identified by the review panel, aspects of management of the patient's drug therapy in the community were examined to assess the preventability of the DRPs. If it was considered that substandard care had been received by the patient, the DRP was categorized as preventable.
Intervention strategies
From the results of phase I, it was considered that an educational intervention to improve prescribing of NSAIDs could potentially lead to fewer DRPs and drugrelated admissions. Three separate strategies for prevention of NSAID-associated adverse events were developed and implemented throughout Tayside region and North East Fife, the catchment area for the large teaching hospital at which re-measurement of the incidence of these DRPs was to take place. Firstly, a written educational intervention was targeted to general practitioners in the area. Secondly, a patient information leaflet was distributed to patients receiving this group of drugs through community pharmacists in the region. Finally, an oral presentation to trainee general practitioners in Tayside was undertaken.
A well-established monthly bulletin existed in the region, which was a known source of information to general practitioners, produced by the pharmaceutical and medical prescribing advisers. One edition of this bulletin was used to provide the educational intervention to general practitioners.
Phase II
To assess the effects of the intervention strategies on the DRPs targeted, a second phase of data collection began immediately after the information bulletin and patient information leaflets were distributed. This was conducted over an 8-month period and was similar to the first, except that only acute medical wards were used on this occasion, since the main interest was in admissions relating to NSAIDs. The proportion of NSAID-related DRPs as a proportion of all DRPs identified was also to be assessed and compared with that in the first data collection period.
Prescribing data from the Management Information and Research Centre of the Pharmacy Practice Division (PPD) was obtained on the number of prescriptions for NSAIDs and ulcer healing drugs for Tayside and for the rest of Scotland for the period of the first data collection (March-December 1992), immediately before the interventions (July 1993) and throughout the remeasurement period (August 1993-March 1994). In addition, anonymized practice data on NSAIDs were obtained from the Prescription Information System for Scotland at Tayside Health Board, to see whether general practitioners in the region had changed their prescribing of this group of drugs over the time period of the study.
Results
Weighted K values for agreement between review panel members ranged from +0.294 to +0.460 in the first phase and were similar in the second, indicating 'fair' to 'moderate' agreement [19] . Inter-reviewer agreement was better than previously reported in a study of hospital admissions [13] -One reviewer considered the control patient to actually have experienced a possible DRP in three cases in phase I and six cases in phase n. Intra-reviewer agreement was assessed by sending a 10% sample of cases to each individual panel member for re-review. Weighted K values for the intra-reviewer agreement ranged from +0.44 to +0.71, demonstrating the reproducibility of the method.
Phase I
Of the 1011 patient admissions which were included in the study, 144 (14.2%) were found to have a definite or possible DRP as identified by the panel. Some patients experienced more than one DRP and, in total, 182 DRPs were identified in these 144 patient admissions. Fifty-four (5-3%) of the admissions were definitely or probably drug-related and a total of 62 DRPs were identified in these admissions. Categories of DRP and their role as a cause of admission are summarized in Table 1 .
The number of women in the study identified as having a DRP was significantly greater than the number of men (16.9 vs 10.5%, x = 7.69, df =\,P = 0.0056). No significant difference was found in marital status or home circumstances. The mean age of patients with DRPs (78.0 ± 6.9 years) was significantly greater than that of patients without DRPs (76.2 ±7.2 years, t = 2.69, P -0.007). Using 5-year age bands, a significant difference in incidence of DRPs between age groups was detected for patients with DRPs compared with those without, (x 2 = 13.22, df = 5, P -0.021), with incidence of DRPs increasing with increasing age. A reduction in incidence of DRPs after 90 years of age was observed, which may be due to greater caution being used in prescribing for very old patients. However, low numbers of patients over 90 years of age were admitted to the study, which may partly explain these results. The mean number of prescribed drugs on admission was significantly greater for patients with a DRP (4.6 ± 2.6) than for those without (35 ± 2.6, t -4.60, P < 0.001). Since no assessment of frailty or cognitive function was made, it is not possible to determine from this study whether these factors influence vulnerability to DRPs.
Adverse drug reactions were the main category of DRP primarily responsible for patient admission, accounting for 64.8% of the admissions due to DRPs. NSAIDs were the main drug group involved, accounting for 15 (42%) of the 36 adverse drug reactions and 15 (28%) of all 54 admissions which were primarily due to a DRP. Therapeutic classes of drugs implicated in adverse drug reactions which were primarily responsible for admission are summarized in Figure 1 . The preventability assessment of DRPs identified is given in Table 2 .
Phase II
The demographics of the study population in phases I and n were similar, allowing comparison of results regarding characteristics of patients with DRPs. The mean number of prescribed drugs per patient was higher than in previously published studies involving elderly patients [1, 11, [20] [21] [22] .
Categories of DRP and their role as a cause of admission during the second phase of data collection are summarized in Table 3 . hi total, 199 (23.2%) of 857 elderly patients in phase II were found to have a definite or possible DRP as categorized by the review panel. Eighty-three (97%) of the admissions were 'definitely' or 'probably' drug-related. Although these percentages are higher than those obtained during phase I, the result for acute medical wards during the first phase were comparable (22.0%, 12.0%). Fifty (18.2%) of the 274 DRPs identified involved a NSAID, while 18.1% of those identified in phase H (33 of 182) DRPs involved this drug group.
During the second phase of data collection, there were 97 prescriptions for NSAIDs in 96 patients on admission. Concurrent prophylactic therapy for gastrointestinal side-effects was prescribed in 30.2% of patients. This compares with 23.6% patients in the first phase, the difference being not significant [Z= 1.12, /> = 0.1314, 95% LCL (lower 95% confidence limit for the larger proportion minus the smaller proportion) = -3.1].
Almost 70% of the elderly patients who were being prescribed a NSAID at the time of admission in the second phase were not taking any prophylactic 
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274 therapy for prevention of gastric or duodenal ulcer. Of these, 21% had additional risk factors for adverse effects of NSAID therapy, as outlined in the intervention bulletin (receiving oral corticosteroids or anticoagulants, past history of peptic ulcer disease, previous NSAID intolerance or previous gastrointestinal symptoms). The remaining patients not taking prophylactic therapy had no additional risk factors, but all were elderly (over 65 years of age) and were therefore considered to fell into a 'higbrisk' group for sideeffects of NSAID therapy. Of the patients being prescribed prophylactic therapy, 51.7% had additional risk factors for adverse effects of NSAIDs.
Indications for a NSAID among the 96 patients were variable. Sixty-four patients (66.7%) were documented as having some form of arthritis-19 (19.8%) with rheumatoid arthritis, 34 (35.4%) with osteoarthritis and 11 (11.5%) with unspecified type. Seven (7.3%) patients were prescribed an NSATD for back pain, seven (7.3%) for generalized aches and pain or shoulder and neck pain, three (3.1%) for gout, two (2.1%) for ankylosing spondylitis, one (1.0%) for systemic lupus erythematosus and one (1.0%) for metastatic bone disease. In the remaining 11 patients (11.5%), no definite indication could be found.
Twenty-two admissions over the 8-month study period were considered by the panel to be 'definitely' or 'probably' due to a NSAID, 21 of which were due to gastrointestinal side-effects. A further eight admissions were thought to have been 'possibly' due to this drug group. Figure 2 shows the admissions over the time period of data collection. The intervention bulletin was sent out at the beginning of August 1993 and a decrease in admissions due to NSAIDs can be seen in the 4 months which follow, but the numbers obtained are small and it is difficult to associate the reduction with the study.
The percentage of patients prescribed NSAIDs in the first phase was 14.1% and during phase n the figure was 11.6%, the difference being close to significance (one-tailed Z test, Z=1.6l, P = 0.0537, 95% LCL = -0.05) When analgesic prescriptions in the two periods were studied, 279% patients in phase I were taking prescribed analgesics (not including NSAIDs), compared with 29.9% of those in phase II. The difference was not statistically significant (Z = 0.95, P = 0.1711, 95% LCL =-1.47). The number of patients taking NSAIDs as a percentage of all those requiring some form of prescribed analgesia was also compared for the two data collection periods. During phase I, this figure was found to be 33.6%, while in phase n it was 27.9%. This was significantly lower than the phase I value, at the 5% level (Z = 1.73, P = 0.0418, 95% LCL = +0.27).
From a comparison of the number of prescriptions for NSAIDs in Tayside to the rest of Scotland, from PPD data, the average monthly figure for the ratio of NSAID prescriptions per day in phase I (12.70) was the same as the figure for July 1993 (12.71), indicating no real change in prescribing of these drugs from the first data collection period to the start of the remeasurement phase.
However, a drop of 6.8% in NSAID prescriptions was seen in Tayside from the PPD data from the period just before to 4 months after the information bulletin was sent out (July-November 1993). The drop for the rest of Scotland over a similar time period was only 1.9%, indicating a greater decrease in prescribing of these drugs in Tayside. A \   2   test was used to test for association between region and number of NSATD prescriptions, and showed a highly significant association (x 2 = 15.49, df=l, P< 0.001). The ratio of prescriptions per day in Tayside compared with the rest of Scotland over these months shows a similar trend, with a decreasing ratio of NSAID prescriptions being dispensed in Tayside.
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Sop Month Figure 2 . Definite or probable non-steroid anti-inflammatory admissions by month, phase n.
The use of misoprostol or an H 2 antagonist was advised in the intervention bulletin for patients being prescribed NSAIDs who fell into certain 'at-risk' groups, elderly patients being one of these. Information on prescribing of ulcer healing drugs in Tayside and in the remainder of Scotland for the first and second data collection periods was obtained and similarly analysed. No trend in prescribing of H 2 antagonists was seen throughout the data collection period. Although an increase in the prescribing of misoprostol was observed, this increase took place in Tayside and the rest of Scotland and was unrelated to the study.
Discussion
The first phase of data collection demonstrated that 5.3% of admissions of elderly patients were definitely or probably drug-related. Of these, 28% involved a NSAID, accounting for 1.4% of all hospital admissions of elderly people. These results and subsequent preventability assessments showed that over 66% of admissions due to NSAID adverse events were considered to be definitely preventable and a further 26.7% were possibly preventable. No single NSAID was implicated in the admissions, although diclofenac was involved in 23% of admissions due to NSAIDs, probably reflecting the popularity of this drug in general practice. Mefenamic acid is far from ideal for use in elderly patients [23] and was responsible for three admissions.
That NSAIDs were the most common cause of admissions due to DRPs was not surprising. It has been estimated that 6% of the population of Tayside take prescribed NSAIDs [24] . NSAIDs account for 25% of all adverse drug reactions reported to the Committee on Safety of Medicines [25] and previous studies have suggested that 0.7 to 1% of all patients taking NSAIDs will be hospitalized due to haemorrhage [26] , with these patients suffering an appreciable mortality rate [27] . hi many cases in which NSAIDs are prescribed, either regular paracetamol or no analgesia at all would be sufficient [28] .
Intervention strategies which targeted this particular group of drugs therefore seemed most likely to produce a measurable effect in reducing hospital admissions due to DRPs. In the second phase of the study, 97% of admissions were due to a DRP, comparable to the results of previous studies [6, 7, 29] There was no significant reduction in total incidence of DRPs or incidence of DRPs related to NSAIDs-thus the intervention strategies were not demonstrably effective. However, the results suggest that there was a reduction in the first 4 months following their implementation which was not subsequently maintained. This suggests that regular reminders are probably required to reinforce good prescribing habits.
hi addition, the figures comparing prescribing of NSAIDs and other analgesics in the two study periods do suggest a difference in prescribing for pain relief in elderly patients between the two data collection periods, with fewer anti-inflammatory prescriptions during the second phase, which may have been due to the interventions undertaken. Also, the PPD prescribing data indicated a statistically significant decrease in prescribing of NSAIDs in Tayside compared with the rest of Scotland over the time period studied.
The contribution of the community pharmacist in avoiding drug-related admissions has not previously been considered [9] [10] [11] [12] [13] [14] . The need to avoid large numbers of prescribed medicines in elderly patients is reinforced by the finding that the mean number of prescribed drugs on admission was significantly greater in both phases for patients with a DRP compared with those without. Unnecessary drugs could be avoided by periodic reassessment of need, and community pharmacists should be vigilant for repeat prescriptions for which the patient appears to have no continued need.
DRPs resulting from self-medication without consulting a doctor have been judged by others as unavoidable [30] . A non-prescription drug was involved in 12 DRPs in this study, four of which were considered to be the cause of the patient's admission. Inappropriate usage was common, with aspirin and paracetamol being used for sleeplessness and indigestion. The community pharmacist has a role in preventing adverse effects of non-prescription medication by determining the suitability of the medicine for the customer before sale and offering appropriate information on potential side-effects.
The percentages of DRPs categorized as definitely or possibly preventable are higher than those reported previously [10, 11, [29] [30] [31] , probably due to the inclusion of the community pharmacist's contribution in the preventability assessment in this study. The figures for preventability of drug-related admissions are also higher than those reported previously [10, 29] Some of the DRPs identified in the present study were regarded as possibly preventable through patient medication records -which recorded details of disease states or present clinical conditions of the patient or of self-medication, neither of which appear to be currently recorded routinely. If pharmacists in the community are to judge whether a particular medicine is appropriate for a patient, they must have access to details on present disease states, as well as a full record of currently prescribed medication and any nonprescription medicines used concurrently. This degree of detailed information held could require patient registration at one particular community pharmacy and would allow patient medication records to be utilized to their full extent.
Conclusion
This study has systematically assessed the incidence of DRPs in elderly patients and has provided further evidence of the dangers of NSAID use in old age. This is the first study to have assessed the impact of intervention strategies directed at the reduction of DRPs. Although the strategies used in this study were not demonstrably effective, the results suggest that a continued programme of education might be effective in reducing the incidence of DRPs due to NSAIDs. The findings lend further weight to the case for improved prescribing with more judicious use of NSAIDs. to undertake currently a wider study involving five European centres, three of which are in the UK. We would like to thank Tayside clinical pharmacists for help in collecting data in the first phase; consultants for access to medical notes and patients; L. Skahill, Pharmaceutical Prescribing Adviser and H. 
Key points
• hi this study 5.3% of elderly patient admissions were definitely or probably drug-related.
• Non-steroid anti-inflammatory drugs were the main drug group involved, being responsible for over onequarter of admissions due to a drug-related problem.
• Two-thirds of admissions due to non-steroid antiinflammatory drug adverse events were considered to be definitely preventable.
• Although intervention strategies were not demonstrably effective, a significant reduction in nonsteroid anti-inflammatory drug prescribing in Tayside compared with the rest of Scotland was observed.
• A continued programme of education is suggested in order to reduce the incidence of drug-related problems due to non-steroid anti-inflammatory drugs.
